| Literature DB >> 23091380 |
Sandhya Vardharajula1, Sk Z Ali, Pooja M Tiwari, Erdal Eroğlu, Komal Vig, Vida A Dennis, Shree R Singh.
Abstract
Carbon nanotubes (CNTs) are emerging as novel nanomaterials for various biomedical applications. CNTs can be used to deliver a variety of therapeutic agents, including biomolecules, to the target disease sites. In addition, their unparalleled optical and electrical properties make them excellent candidates for bioimaging and other biomedical applications. However, the high cytotoxicity of CNTs limits their use in humans and many biological systems. The biocompatibility and low cytotoxicity of CNTs are attributed to size, dose, duration, testing systems, and surface functionalization. The functionalization of CNTs improves their solubility and biocompatibility and alters their cellular interaction pathways, resulting in much-reduced cytotoxic effects. Functionalized CNTs are promising novel materials for a variety of biomedical applications. These potential applications are particularly enhanced by their ability to penetrate biological membranes with relatively low cytotoxicity. This review is directed towards the overview of CNTs and their functionalization for biomedical applications with minimal cytotoxicity.Entities:
Keywords: biomedical applications; carbon nanotubes; cytotoxicity; functionalization
Mesh:
Substances:
Year: 2012 PMID: 23091380 PMCID: PMC3471599 DOI: 10.2147/IJN.S35832
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Functionalized carbon nanotubes and reduced cytotoxic effects
| Functional group or structure | Toxicological studies | Application | Target site | Reference |
|---|---|---|---|---|
| Acid-oxidized SWCNTs | Apoptosis studies showed no apparent cell toxicity | Intracellular protein transporters | Mammalian cells | Kam and Dai |
| Acid-treated, water-soluble SWCNTs | No changes in cell viability or structure in lysosomes and cytoplasm | Human monocyte– derived macrophage cells | Porter et al | |
| Purified COOH–SWCNTs | No cytotoxicity | Pharmacological applications | Cultured mammalian cells | Wang et al |
| Oxidized ultrashort SWCNTs | Showed no cytotoxic effects | Intracellular delivery of oligonucleotide molecules | Human macrophages | Crinelli et al |
| Amine-terminated CNTs | Cross cellular membrane without cytotoxicity | Delivery of amino acids peptides, nucleic acid, or drugs | Pantarotto et al | |
| SWCNT–PL–PEG | Gene silencing with no apparent cytotoxic effects | SH–small interferingRNA delivery | Human T cells | Liu et al |
| SWCNT–PEG–drug | Decreased reactive oxygen species– mediated toxicological response and exhibited less cytotoxicity | Drug delivery | Neuronal PC12 cells | Zhang et al |
| SWCNT–PEG–cisplatin/ doxorubicin | Remarkable reduction of cytotoxicity | Drug-delivery and imaging tool | Human cancer cells/mice | Bottini et al |
| SWCNT–PEG–mAb ( | Without harming adjacent normal cells | Cancer-cell targeting | Portney et al | |
| SWCNT–PEG | Revealed no evidence of toxicity over 4 months | Mice | Schipper et al | |
| MWNT–CS–(PC) | Chitosan and PC reduced the cytotoxic effects on normal cells with specific photo-induced toxicity towards malignant cells | Photothermal therapy | MCF-7, HepG2 and L-O2 cell lines | Liao and Zhang |
| Polyoxylethylene sorbitan monooleate (PS80) CNTs | Suppressed cytotoxicity | Human lung mesothelium cells (MSTO-211-H) | Wick et al | |
| HMDA–SWCNTs; PDDA chloride–SWCNTs | Negligible cytotoxic effects | Intracellular delivery of negatively charged biomolecules | Rat heart cells | Krajcik et al |
| SWCNTs with human serum proteins | Blood proteins altered SWCNT cellular interaction pathways and reduced cytotoxicity | Biological applications | Human acute monocytic leukemia cell lines and human umbilical vein endothelial cells | Ge et al |
| BSA-dispersed SWCNTs | No acute deleterious cellular effects | Human mesenchymal stem cells and HeLa cells | Holt et al | |
| Albumin–SWCNTs | Induced cyclooxygenase-2 and modulating toxicity effects of SWCNTs | RAW 264.7 macrophage cell lines | Dutta et al | |
| Streptavidin–CNT– protein conjugates | No cytotoxic effects on adjacent cells | Specific drug delivery | Cancer cells | Balavoine et al |
| DNA-encased MWCNTs | Does not exert cytotoxic effect on lymphocytes | Selective thermal ablation of malignant tissue in vivo | In vivo | Ghosh et al |
| Lectin-functionalized CNTs | Increase in cell viability without signs of apoptosis | Nanovaccine fabrication | J774A macrophage (MOs) cell line | Montes- Fonseca et al |
| Fluorescent–CNT-FITC/ biotin conjugates | Reduced cytotoxicity | Delivery systems | HL60 cells | Bianco et al |
| Cationic fCNTs | Lowers cytotoxicity in vitro | Delivery of drugs and biomolecules | CHO, 3T3 fibroblast, Jurkat, HL60 cell lines | Shi Kam et al |
Abbrevations: CNTs, carbon nanotubes; fCNTs functionalized carbon nanotubes; SWCNTs, single-walled carbon nanotubes; PL, phospholipid; PEG, poly(ethylene glycol); mAb, monoclonal antibody; MWCNTs, multiwalled carbon nanotubes; CS, chitosan; PC, phycocyanin; CTAB, cetyltrimethylammonium bromide; HMDA, hexamethylenediamine; PDDA, polydiallyldimethylammonium; BSA, bovine serum albumin.
Figure 1Overview of functionalization of carbon nanotubes (CNTs) using different molecules and their biomedical applications.
Abbreviations: SWCNT, single-walled carbon nanotube; siRNA, small interfering RNA; PEG, polyethylene glycol.
Figure 2π–π stacking interaction between single-walled carbon nanotube (SWCNT) and protein molecules.
Figure 3DNA wrap around single-walled carbon nanotubes (SWCNTs) to form tight helices, forming noncovalent conjugates with CNTs.
Figure 4Functionalization of multiwalled carbon nanotube (MWCNT) with chitosan (CS) conjugated to phycocyanin (PC) (photodynamic therapy [PDT] and photothermal therapy [PTT] agent) for PDT and PTT cancer therapy.